gabapentin has been researched along with Idiopathic Parkinson Disease in 15 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To review the use of the antiepileptic drug gabapentin for the treatment of various types of tremor." | 8.82 | Gabapentin for the treatment of tremor. ( Bertoni, JM; Faulkner, MA; Lenz, TL, 2003) |
| "To review the use of the antiepileptic drug gabapentin for the treatment of various types of tremor." | 4.82 | Gabapentin for the treatment of tremor. ( Bertoni, JM; Faulkner, MA; Lenz, TL, 2003) |
| " We compared new users of recently approved versus established medications for management of diabetic peripheral neuropathy (pregabalin versus gabapentin), Parkinson disease psychosis (pimavanserin versus quetiapine), and epilepsy (brivaracetam versus levetiracetam)." | 4.31 | Channeling of New Neuropsychiatric Drugs-Impact on Safety and Effectiveness Studies. ( Abraham, DS; Blank, LJ; Gray, SL; Hennessy, S; Leonard, CE; Nguyen, TPP; Thibault, D; Weintraub, D; Willis, AW, 2023) |
| "We identified 52,249 patients with neuropathy on gabapentinoids, 5,246 patients with neuropathy on SNRIs, 19,820 patients with dementia on cholinesterase inhibitors, and 3,130 patients with PD on dopamine agonists." | 3.96 | Association of out-of-pocket costs on adherence to common neurologic medications. ( Banerjee, M; Burke, JF; Callaghan, BC; Esper, GJ; Kerber, KA; Magliocco, B; Reynolds, EL; Skolarus, LE, 2020) |
| "The phenytoin treatment causes cerebellar defect and anemia." | 2.82 | The interplay of epilepsy with impaired mitophagy and autophagy linked dementia (MAD): A review of therapeutic approaches. ( Agrawal, M; Dhurandhar, Y; Panda, SP, 2022) |
| "Monosymptomatic rest tremor has recently been shown to be associated with decreased fluorodopa uptake on the positron emission tomography scan suggesting its relationship to Parkinson disease." | 2.42 | Tremor. ( Sethi, KD, 2003) |
| "Essential tremor is a common movement disorder in adults that interferes with the performance of functional and social activities." | 2.42 | Essential tremor: diagnosis and treatment. ( Chen, JJ; Swope, DM, 2003) |
| "Tremor-predominant Parkinson's disease is characterised by prominent tremor of one or more limbs with a relative lack of significant rigidity and bradykinesia." | 2.41 | Tremor-predominant Parkinson's disease. Approaches to treatment. ( Koller, W; Marjama-Lyons, J, 2000) |
| "Chronic pain is the most common non-motor symptom among Parkinson's disease (PD) patients, with 1." | 1.51 | Effects of subthalamic deep brain stimulation with gabapentin and morphine on mechanical and thermal thresholds in 6-hydroxydopamine lesioned rats. ( Feustel, P; Kaszuba, BC; Maietta, T; Pilitsis, JG; Shin, DS; Slyer, J; Stapleton, A; Walling, I, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Panda, SP | 1 |
| Dhurandhar, Y | 1 |
| Agrawal, M | 1 |
| Abraham, DS | 1 |
| Nguyen, TPP | 1 |
| Blank, LJ | 1 |
| Thibault, D | 1 |
| Gray, SL | 1 |
| Hennessy, S | 1 |
| Leonard, CE | 1 |
| Weintraub, D | 1 |
| Willis, AW | 1 |
| Reynolds, EL | 1 |
| Burke, JF | 1 |
| Banerjee, M | 1 |
| Kerber, KA | 1 |
| Skolarus, LE | 1 |
| Magliocco, B | 1 |
| Esper, GJ | 1 |
| Callaghan, BC | 1 |
| Hsu, CH | 1 |
| Yu, SM | 1 |
| Lau, SC | 1 |
| Chen, YL | 1 |
| Pei, D | 1 |
| Liu, IC | 1 |
| Kaszuba, BC | 1 |
| Maietta, T | 1 |
| Walling, I | 1 |
| Feustel, P | 1 |
| Stapleton, A | 1 |
| Shin, DS | 1 |
| Slyer, J | 1 |
| Pilitsis, JG | 1 |
| Ege, F | 1 |
| Koçak, Y | 1 |
| Titiz, AP | 1 |
| Oztürk, SM | 1 |
| Oztürk, S | 1 |
| Ozbakir, S | 1 |
| Erol, C | 1 |
| Ozben, S | 1 |
| Ozer, F | 1 |
| Cetin, S | 1 |
| Tiras, R | 1 |
| Sarbaz, Y | 1 |
| Gharibzadeh, S | 1 |
| Towhidkhah, F | 1 |
| Faulkner, MA | 1 |
| Bertoni, JM | 1 |
| Lenz, TL | 1 |
| Sethi, KD | 1 |
| Chen, JJ | 1 |
| Swope, DM | 1 |
| Raju, PM | 1 |
| Walker, RW | 1 |
| Lee, MA | 1 |
| Poujois, A | 1 |
| Vidailhet, M | 1 |
| Trocello, JM | 1 |
| Bourdain, F | 1 |
| Gaymard, B | 1 |
| Rivaud-Péchoux, S | 1 |
| Chaná, P | 1 |
| de Marinis, A | 1 |
| Barrientos, N | 1 |
| Marjama-Lyons, J | 1 |
| Koller, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Oral Gabapentin and Pregabalin in Postoperative Pain Control After Photorefractive Keratectomy: a Prospective, Randomized Study.[NCT00954187] | 8 participants (Actual) | Interventional | 2009-11-30 | Terminated (stopped due to PI left institution) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for gabapentin and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
The interplay of epilepsy with impaired mitophagy and autophagy linked dementia (MAD): A review of therapeutic approaches.
Topics: Anticonvulsants; Carbamazepine; Dementia; Epilepsy; Felbamate; Gabapentin; Humans; Inflammasomes; La | 2022 |
Gabapentin for the treatment of tremor.
Topics: Acetates; Adult; Aged; Amines; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Gabapentin; ga | 2003 |
Tremor.
Topics: Acetates; Amines; Anticonvulsants; Antiparkinson Agents; Cyclohexanecarboxylic Acids; Diagnosis, Dif | 2003 |
Essential tremor: diagnosis and treatment.
Topics: Acetates; Amines; Cyclohexanecarboxylic Acids; Diagnosis, Differential; Essential Tremor; Gabapentin | 2003 |
Tremor-predominant Parkinson's disease. Approaches to treatment.
Topics: Acetates; Amantadine; Amines; Antiparkinson Agents; Botulinum Toxins; Cholinergic Antagonists; Clona | 2000 |
2 trials available for gabapentin and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Effect of gabapentin on oculomotor control and parkinsonism in patients with progressive supranuclear palsy.
Topics: Aged; Amines; Antiparkinson Agents; Cyclohexanecarboxylic Acids; Eye Movements; Female; Gabapentin; | 2007 |
Gabapentin and motor fluctuations in Parkinson's disease.
Topics: Acetates; Aged; Amines; Antiparkinson Agents; Cyclohexanecarboxylic Acids; Drug Therapy, Combination | 1997 |
8 other studies available for gabapentin and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Channeling of New Neuropsychiatric Drugs-Impact on Safety and Effectiveness Studies.
Topics: Adult; Cross-Sectional Studies; Diabetic Neuropathies; Epilepsy; Gabapentin; Humans; Levetiracetam; | 2023 |
Association of out-of-pocket costs on adherence to common neurologic medications.
Topics: Adult; Aged; Antiparkinson Agents; Cholinesterase Inhibitors; Dementia; Excitatory Amino Acid Antago | 2020 |
Restless legs syndrome/Willis-Ekbom disease in type 2 diabetes as the initial manifestation of Parkinson's disease and major cardiovascular disease.
Topics: Aged; Amines; Analgesics; Anticonvulsants; Antihypertensive Agents; Antiparkinson Agents; Aspirin; B | 2017 |
Effects of subthalamic deep brain stimulation with gabapentin and morphine on mechanical and thermal thresholds in 6-hydroxydopamine lesioned rats.
Topics: Animals; Chronic Pain; Deep Brain Stimulation; Disease Models, Animal; Gabapentin; Male; Morphine; O | 2019 |
Gabapentin-Induced myoclonus: case report.
Topics: Aged, 80 and over; Amines; Antiparkinson Agents; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Amin | 2008 |
Bilateral ballism induced by gabapentin in idiopatic Parkinson's disease.
Topics: Aged, 80 and over; Amines; Anticonvulsants; Back Pain; Comorbidity; Cyclohexanecarboxylic Acids; Dys | 2009 |
Pathophysiology of freezing of gait and some possible treatments for it.
Topics: Amines; Cyclohexanecarboxylic Acids; Dopamine; Excitatory Amino Acid Antagonists; Gabapentin; Gait; | 2012 |
Dyskinesia induced by gabapentin in idiopathic Parkinson's disease.
Topics: Aged; Amines; Antiparkinson Agents; Cyclohexanecarboxylic Acids; Dyskinesia, Drug-Induced; Gabapenti | 2007 |